Status:
COMPLETED
Implementation of COVID-19 Testing Strategies in Community Health Centers
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Dana-Farber Cancer Institute
Harvard School of Public Health (HSPH)
Conditions:
Covid19
Eligibility:
All Genders
Phase:
NA
Brief Summary
This project is part of a competitive revision to accelerate COVID-19 testing in underserved populations. The overall aim is to implement strategies to expand COVID testing in hotspot communities in M...
Eligibility Criteria
Inclusion
- Participants are patients at the intervention or control CHCs or members of the local community. The participating sites constitute one group; a set of matched control CHCs that will conduct testing as usual constitute the second group.
Exclusion
- None
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2022
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04802187
Start Date
December 1 2020
End Date
July 15 2022
Last Update
November 8 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts League of Community Health Centers
Boston, Massachusetts, United States, 02108
2
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114